Related by context. All words. (Click for frequent words.) 62 advances 58 Advancements 52 Gains 51 Declines 49 advancements 49 Breakthroughs 49 Expands Scope 49 Study Predicts 49 Stays Alive 48 Increases 48 Helps Improve 48 Straight Sets 48 Forges Ahead 48 Sixth Straight 48 Technological Advances 47 Opens Door 47 Changes 47 Makes Strides 47 Moves Forward 47 Psychiatric Treatment 47 Study Uncovers 47 Awaits Approval 47 Moves Closer 47 Propels 47 Technological Developments 47 Panel Backs 47 Drop Sharply 47 Strikes Down 47 Snaps Losing Streak 47 Looks Promising 47 Improved 47 Fourth Straight 47 Defending Champ 47 Stays Strong 47 Lower Than Expected 47 Making Inroads 46 Bracket Update 46 Challenges Loom 46 Miniaturization 46 Diversifies 46 Paves Way 46 Accelerates 46 Could Revolutionize 46 Increase 46 Jobless Claims Increase 46 Falters 46 More Than Doubles 46 Drops 46 Gains Ground 46 Dramatic Increase 46 Court Upholds Ruling 46 Gaining Momentum 46 Costs Update2 46 Losses 46 Rises Sharply 46 Ramps Up Production 46 Cruises Into 46 Successfully Concludes 46 Bodes Well 46 Seen Boosting 46 Report Suggests 46 Boost Efficiency 46 Update6 46 Record Highs 46 Boosts 46 Validates 46 Eases 46 Ramping Up 46 Grants Awarded 46 Induced Pluripotent Stem Cells 45 Further Validates 45 Slow Start 45 Less Than Expected 45 Could Pave Way 45 Resolve Dispute Over 45 Defeats 45 Technological advancements 45 Outstrip 45 Catches Break 45 Surge Lifts 45 Purchases 45 Than Forecast 45 Stabilizes 45 Restructures Debt 45 Agreement Reached 45 U.K. Stocks 45 Pursues 45 Lawsuit Filed Over 45 Rapidly Expanding 45 Could Trigger 45 Procures 45 Study Underscores 45 Renegotiates 45 Refocuses 45 Record Levels 45 Rate Increases 45 Pulls Off 45 Takes Shape 45 Report Analyzes 45 Decline 45 Costs Update1 45 Little Changed 45 Profit Beats Estimates 45 Expanded 45 Remain Flat 45 Makes Inroads 45 Gains Momentum 45 Imaging Technique 45 Fall Sharply 45 Eighth Straight 45 Squeezes 45 Hurdles Remain 45 Being Studied 45 Fifth Straight 45 Avoids Upset 45 Submits Proposal 45 Must Adapt 45 Surges 45 Foreshadows 45 Faces Uncertain 45 Holds Steady 45 Underscores Need 45 MarketsandMarkets Global 45 Significant Increase 45 Extends Gains 45 Rise Slightly 45 Surpasses Expectations 45 Grow Faster 45 Dramatically Increases 45 Futures Climb 45 Strengthens Balance Sheet 45 Gain Traction 45 Report Outlines 45 Rates Rise 45 Seventh Straight 45 Holding Steady 45 Hits Milestone 45 Looks Toward 44 Patent Dispute 44 Hangs Tough 44 Moves Ahead 44 Gains Traction 44 Evolves 44 Gets Boost From 44 Subsidiary Wins 44 Remains Committed 44 Completes Expansion 44 Widens 44 Tops Forecasts 44 Make Inroads 44 Yen Strengthens 44 Fend Off 44 Modifications 44 Inches Up 44 Envisions 44 Stocks Pare Losses 44 Overhauls 44 Sees Possible 44 Proves Successful 44 Drops Sharply 44 Modest Gains 44 Shifts Focus 44 Lowest Ever 44 Achieves Milestone 44 Panel Advises 44 Test Detects 44 Pulls Upset 44 Profits Climb 44 Stocks Gain 44 Prices Dip 44 Remain Intact 44 Slightly Lower 44 Fizzles 44 Rises 44 Reaches Record 44 Profit Jumps 44 Set Sights 44 Comeback Win 44 Gets Boost 44 Ninth Straight 44 Cruises Past 44 Profits Soar 44 Helps Identify 44 Improves Quality 44 Pushes Back 44 Penetrates 44 Improvements 44 Differing Views 44 Interest Rate Increases 44 Panel Endorses 44 Prices Continue 44 Mostly Steady 44 Dramatically Reduce 44 Fifth Consecutive 44 Oil Prices Plummet 44 Staves Off 44 Remain Strong 44 Sees Steady 44 Under Scrutiny 44 Erases 44 Forecast Predicts 44 Ticks Higher 44 Demands 44 Nears Record 44 Denies Petition 44 Momentum Builds 44 Temporarily Halts 44 Trend Toward 44 Treads Water 44 Posts Loss 44 Up Sharply 44 Plant Shutdowns 44 Clears Way 44 Shrinks 44 Makes Significant 44 Nanophase Announces 44 Nanoimprint Lithography 44 Futures Rise 44 Inflation Worries 44 Inches Closer 44 Boost Output 44 technological advances 44 Demand Surges 44 Earnings Soar 44 Slight Gains 44 Weaker Dollar 44 Sentence Sought 44 Pushes 44 Rates Decline 44 Significantly Increases 44 Net Profit Drops 44 Profits Slip 44 Clears Path 44 Deals Blow 44 Slightly Higher 44 Scrutinizes 44 Prices Climb 44 Sees Strong 44 Helps Boost 44 Aims 44 Poses Risk 44 Makes Headway 44 Growth Accelerates 44 Help Detect 44 Stocks Surge 44 Foresees 44 Toughens 44 Immune Cells 44 Fatten Up 44 Entry Into 44 Profit Drops 43 Sets Sights 43 Proliferate 43 Stocks Climb 43 Third Quarter Profit Rises 43 Broadens Its 43 Lung Cancer Survival 43 Extends 43 Reconsiders 43 Stocks Decline 43 Yen Weakens 43 Upsets 43 Prices Surge 43 Panel Suggests 43 Lawmakers Seek 43 Takes Step Toward 43 Wins Approval 43 Move Toward 43 Permits Issued 43 Prospects Dim 43 Net Loss Narrows 43 Findings Reveal 43 Crimps 43 Exec Says 43 Move Closer 43 Debated 43 Sees Rise 43 Patent Ruling 43 Face Hurdles 43 Reduces Debt 43 Secures Funding 43 Judge Nixes 43 Moves Towards 43 Extends Commitment 43 Successes 43 Forgoes 43 Spur Growth 43 Different Paths 43 Protein Linked 43 Helps Ensure 43 Results Confirm 43 Remains Steady 43 Growth Spurt 43 Japanese Stocks Rise 43 Immunomedics Announces 43 Hits Speed Bump 43 Heading Toward 43 Prices Drop 43 Lowest Level 43 Summarizes 43 Slowing Growth 43 Gain Update2 43 Price Hikes 43 Growth Slowing 43 Down Sharply 43 Quantum Dots 43 Reduces Risk 43 Milestone Payment 43 Stocks Advance 43 Broadened 43 Ramps Up 43 Decline Update3 43 Profit Tumbles 43 Outlook Gloomy 43 Edges Out 43 Will Overtake 43 Gene Silencing 43 Contract Signings 43 Showdown Looms 43 Loses Ground 43 Judge Dismisses Lawsuit 43 Reinforces Commitment 43 Sees Significant 43 Momentum Grows 43 Hold Off 43 Wipes Out 43 Concerns Remain 43 Withstands 43 Growing Faster Than 43 Bigger Than Expected 43 Pares Loss 43 Inflation Fears 43 Develop Innovative 43 Quadruples 43 Remains Optimistic 43 Seeks Approval 43 Investors Await 43 Heightens 43 Trustees Approve 43 Raises Rates 43 Sector Wrap 43 Profit Leaps 43 Expand Collaboration 43 Patents Issued 43 Higher Than Expected 43 Cuts Costs 43 Outlook Uncertain 43 Moves Toward 43 Discontinues 43 #,#,# #,#,# Accrued liabilities 43 Li Ion Batteries 43 Rally Fizzles 43 Provides Insights 43 Weak Dollar 43 Rate Drops 43 Too Costly 43 Less Invasive 43 Firms Seek 43 Nanopore 43 Derails 43 Stocks Plummet 43 Must Rethink 43 Raises Questions 43 Accelerate Growth 43 Dramatically Increase 43 Sales Soar 43 Outstrips 43 Invest Heavily 43 Profit Misses Estimates 43 Nudges 43 Growth Slows 43 Could Cripple 43 Update2 43 Furthers Commitment 43 Income Rises 43 Pushes Ahead 43 Consolidates 43 Randomized Trials 43 Panel Rejects 43 Argues Against 43 Moves 43 Slumps 43 Steadies 43 Chip Makers 43 Futures Decline 43 Largest Ever 43 Study Examines 43 Firm Sues 43 Keeps Growing 43 Imperil 43 Revised Upward 43 Sees Huge 43 Gets Clearance 43 Exceeds Forecasts 43 Could Derail 43 Modestly Higher 43 Significantly Reduce 43 Moves Step Closer 43 Contracts Awarded 43 Edges Up 43 Bucking Trend 43 Bounces Back 43 Experts Urge 43 Finds Itself 43 Important Role 43 Targeted Therapies 43 Eases Rules 43 Drags Down 43 Feds Propose 43 Shortens 43 Brain Wiring 43 Update7 43 Challenges Remain 43 Backs Away 43 Hard Fought 43 Panel Upholds 43 Sees Weak 43 Reverses Loss 43 Improves Survival 43 Profit Declines 43 Profit Soars 43 Underwrites 43 Seeks Answers 43 Deflates 43 Averts 43 Forecast Raised 43 Amends 43 Hear Arguments 43 Economy Slows 43 Remains Strong 43 Into Semis 43 Play Crucial Role 43 Faces Tough 43 Rise Modestly 43 Oil Tumbles 43 Overcomes Slow Start 43 Remain Stable 43 Remains Confident 43 Ceases 43 Remain Unbeaten 43 Climbs 42 Overwhelms 42 Proves Effective 42 Prices Decline 42 Announcement Regarding 42 Panel Votes 42 Significant Improvements 42 Quarterly Loss 42 Rain Delays 42 Regulators Warn 42 Gathers Steam 42 Tightening Concerns 42 Sets Stage 42 Battle Heats Up 42 Genetic Tests 42 Be Delayed 42 Midday Trading 42 repurchase FHLBNY 42 Improves Productivity 42 Stocks Drop 42 Doubles Capacity 42 Remains Flat 42 Expects Higher 42 Quarterly Profit 42 Ends Skid 42 Tightens 42 Bankruptcy Filings 42 Expands Capabilities 42 Profits Plunge 42 Higher Yielding 42 Questions Arise 42 Tumor Cells 42 Dips Slightly 42 Make Headway 42 Nanoparticle 42 Stocks Erase Losses 42 Update# 42 Offers Unprecedented 42 2nd Qtr Profit 42 Enables Faster 42 Raises Forecast 42 Approves 42 Boosts Productivity 42 Leapfrogs 42 Gap Narrows 42 Poses Risks 42 Enters Final 42 Shares Plummet 42 Strives 42 Increased 42 Increased Scrutiny 42 Percent Jump 42 Boosts Profit 42 Overcome Barriers 42 Loses Bid 42 Outlook Brightens 42 Sharply Higher 42 Remains Sluggish 42 Overtime Win 42 Stocks Mixed 42 Device Helps 42 Manufacturing Capabilities 42 Expands Coverage 42 Remains Elusive 42 Sees Increase 42 Softens 42 Yield Spreads 42 Furthers 42 Pulling Plug 42 Results Disappoint 42 Interest Rate Speculation 42 Grapples With 42 Plunges 42 Takes Steps 42 Can Predict 42 Ekes Out 42 1Q Profit 42 Interest Rate Concern 42 Profit Tops Estimates 42 Problems Persist 42 Erase Gains 42 Hears Testimony 42 Upgrades 42 Title Hopes 42 Temporarily Suspends 42 Loss Widens 42 Fee Hikes 42 Edges Past 42 Suffers Setback 42 Rise Sharply 42 Little Changed Before 42 Settle Dispute Over 42 Revenues Decline 42 Endows 42 Enacts 42 Uptick 42 Reverses Gains 42 Helps Diagnose 42 Talks Collapse 42 Thin Film Batteries 42 Broadens 42 Leaves Door 42 Weighed Down 42 Expand Scope 42 Language Barrier 42 Achieves Significant 42 Could Hurt 42 Interest Rates Rise 42 Gold Nanorods 42 Speeds Up 42 Hits Snag 42 Rising Interest Rates 42 Fending Off 42 Up Slightly 42 Earnings Decline 42 Sues Feds 42 Lays Groundwork 42 Faces Obstacles 42 Inventories #,#,# #,#,# [001] 42 Slows Down 42 Futures Slip 42 Looks Ahead 42 Pressure Builds 42 Cost Structure 42 Could Generate 42 Being Tested 42 Churns Out 42 Sees Profit 42 Outpaces 42 Gloomy Outlook 42 Posts Profit 42 Takeover Speculation 42 Margin Expansion 42 Oil Surges 42 Woes Hit 42 Edges Down 42 Antitrust Scrutiny 42 Stock Plunges 42 Bulks Up 42 Highlights Importance 42 Bogs Down 42 Beats Expectations 42 Slight Improvement 42 Sees Surge 42 Ramp Up 42 Exercises Option 42 Device Makers 42 Remains Weak 42 Cuts Rates 42 Become Reality 42 Bond Yields 42 Shares Surge 42 Faces Uncertain Future 42 Larger Than Expected 42 Recommends Changes 42 Attract Buyers 42 Sees Slower 42 Continue Slide 42 Quantifies 42 Rheumatoid Arthritis Drug 42 Inch Closer 42 Stocks Stabilize 42 Beats Forecasts 42 Steady Ahead 42 Judge Tosses 42 Differs From 42 Complies With 42 Appears Poised 42 Soybeans Grains 42 Reverses Course 42 Could Threaten 42 Remains Upbeat 42 Uncertainty Remains 42 Helps Predict 42 Lawmakers Oppose 42 Modifies 42 Sees Higher 42 Stocks Retreat 42 Posts 2Q Loss 42 Quarterly Profit Drops 42 Profit Falls 42 Plummets 42 Widely Available 42 Profit Slumps 42 Scraps Plans 42 Patent Lawsuit 42 Costs Rise 42 Stocks Sharply Lower 42 Faces Uphill Battle 42 Loosens 42 Profit Surges 42 Narrowly Mixed 42 Inch Toward 42 Questions Loom 42 Detect Cancer 42 Rally Past 42 Reaches Goal 42 Slips 42 Faces Challenges 42 Increase Efficiency 42 Be Studied 42 Knockout Stages 42 Soars 42 Second Quarter Profit Rises 42 Stocks Recover 42 Sets Goal 42 Judge Clears Way 42 Downsizes 42 Profit Plunges 42 Loss Shrinks 42 Stymies 42 Panel Discusses 42 Invalidate 42 Gives Boost 42 Stem Cell Breakthrough 42 Latest Advancements 42 Treatment Reduces 42 Mostly Higher 42 Continues Climb 42 Lowers Rates 42 Lags Behind 42 Woes Remain 42 Grows Rapidly 42 Underpin 42 Pose Risks 42 Lowers Forecast 42 Pressure Mounts 42 Demonstrates Ability 42 Looms Large 42 Biocompatible 42 Tourney Title 42 Is Little Changed 42 Grains Mixed 42 Double Digit 42 Deadline Extended 42 Ups Ante 42 Therapeutic Targets 42 Strengthens 42 Dollar Retreats 42 Yields Climb 42 Drug Fails 42 Formalizes 42 Slower Growth 42 Reverses 42 Foray Into 42 Lagging Behind 42 Revises Upward 42 Stages Comeback 42 Lawmakers Approve 42 Profit Climbs 42 Advance 42 Largely Unchanged 42 Costs Update4 42 Could Complicate 42 Doubles Size 42 Verifies 42 Upholds Ruling 42 Fourth Quarter Profit Rises 42 Exec Sees 42 Nudges Up 42 Nearly Triples 42 Gains Update2 42 Reinforces 42 Offers Glimpse 42 Profits Rise 42 Impairs 42 Stocks Rebound 42 Announces Discontinuation 42 Stocks Drop Paced 42 Seeks 42 Exceeds Goal 42 Extend Gains 42 Extend Partnership 42 Faces Criticism 42 Extend Rally 42 Implant Sciences Announces 42 Trims Loss 42 Weekly Gain 42 Passes Milestone 42 Sharpens 42 Snags 42 Japanese Stocks Decline 42 Traders Pare Bets 42 To Undergo 42 Laptop Theft 42 Regents Approve 42 4Q Profit Surges 42 Sales Disappoint 42 Debate Rages 42 Little Changed Ahead 42 Panel Approves 41 Profit Growth Slows 41 Opportunities Exist 41 Help Predict 41 Ends Losing Streak 41 Role Reversal 41 Shares Climb 41 Asian Stocks Decline 41 Offers Incentives 41 Formally Launches 41 Restate Financials 41 More Than Doubled 41 Could Harm 41 Classifies 41 Pulls Back 41 Decides Against 41 Cocaine Seizure 41 Profits Surge 41 European Stocks Climb 41 Mideast Unrest 41 Gets Approval 41 Senate Panel Approves 41 Analyst Predicts 41 Update1 41 Refines 41 Report Assesses 41 Vote Nears 41 Opens Doors 41 Lose Ground 41 Rapidly Evolving 41 Extend Deadline 41 Slips Slightly 41 Reports 4Q Loss 41 Momentum Continues 41 Volatile Trading 41 Knocked Off 41 Rally Loses Steam 41 Profitable Quarter 41 Eke Out 41 Shrug Off 41 2Q Profit 41 Panel Nixes 41 Overestimated 41 Advancing 41 Antipsychotic Drugs 41 Leads Effort 41 Enable Faster 41 Key Enabler 41 Continues Slide 41 Resolve Dispute 41 Continues Commitment 41 Help Diagnose 41 Cervical Dysplasia 41 Growth Slowed 41 Update8 41 Obstacles Remain 41 Faster Than Expected 41 Halted 41 Readied 41 Helps Lift 41 Shares Soar 41 Sputters 41 Advisers Urge 41 Update5 41 Subsidiary Enters 41 Reduced Costs 41 Lowest Rate 41 Analyst Downgrade 41 Reduces Size 41 Narrows Loss 41 Dragged Down 41 Closes Previously Announced 41 Breast Tumors 41 Economists React 41 Probably Fell 41 Gaining Steam 41 Raises Concerns Over 41 Gets Underway 41 Midafternoon Trading 41 Recession Worries 41 Reshapes 41 Seeks Delay 41 Important Milestone 41 Improves 41 Highlight Importance 41 Stocks Bounce Back 41 Japanese Stocks Climb 41 Yen Declines 41 Reduced Risk 41 Benefits Outweigh 41 Study Reinforces 41 House Panel Approves 41 Jobless Claims Dip 41 Beats Forecast 41 Nears Completion 41 Gene Linked 41 Stocks Tumble 41 Profits Jump 41 Privacy Breaches 41 Provides Comprehensive 41 Deadline Looms 41 Growth Trajectory 41 Downside Risks 41 KLCI Futures 41 Compromise Reached 41 Costs Soar 41 Related Deaths 41 Becomes Reality 41 Rain Washes Out 41 innovations 41 1st Qtr Profit 41 Sees Positive 41 Stocks Rise 41 Rate Climbs 41 Considers Options 41 Judge Hears Arguments 41 Detecting Breast Cancer 41 Could Prove Costly 41 Pft Taking 41 Slower Than Expected 41 Remain Unchanged 41 Receives Initial 41 Marks Milestone 41 Boosts Forecast 41 Remains Unclear 41 Demonstrates Commitment 41 More Than Triples 41 Clears Hurdle 41 Holds Gains 41 Receives Favorable Ruling 41 Lawmakers Reject 41 Newly Identified 41 Sweeping Changes 41 Posts Wider Loss 41 Genes Identified 41 Re Examine 41 Study Shows Significant 41 Panel Examines 41 Liquidates 41 Gain Led 41 RNAi Therapeutics 41 4Q Loss Widens 41 Talks Continue 41 Signs Agreements 41 Panel Debates 41 Exceeds Expectations 41 Complaint Filed 41 Mental Decline 41 Monetizes 41 Profit Doubles 41 Erase Losses 41 Gains Update1 41 Higher Interest Rates 41 Correlation Between 41 Controversy Surrounds 41 Delving Into 41 Enhancements 41 Drug Makers 41 Spend Billions 41 Downward Trend 41 Could Prove 41 Stocks Pare Gains 41 Casts Shadow Over 41 Outruns 41 Favorable Ruling 41 Finishes Up 41 Overshadows 41 1Q Loss 41 Capabilities 41 Update4 41 Secures Long Term 41 Profit Triples 41 Probe Widens 41 4Q Loss Narrows 41 Ease Limits 41 Gets Bigger 41 Lifts Restrictions 41 Hits Record 41 Selling Pressure 41 MARKET TALK JP 41 Mixed Fortunes 41 Interest Rate Hikes 41 Interferes With 41 Significantly Expand 41 Profit Dips 41 Feds Seek 41 Effort Aims 41 Lawsuit Challenges 41 ER Visits 41 Could Save Lives 41 Innovative Approach 41 Structural Changes 41 Debate Heats Up 41 Sinks Into 41 Device Maker 41 Versus Dollar 41 Accepts Bid 41 Penalizes 41 Low Voter Turnout 41 Court Reinstates 41 Hits Lowest Level 41 Lawmakers Propose 41 Decline Update1 41 Effort Needed 41 Fluctuate 41 Outweigh 41 Pins Hopes 41 Builds Momentum 41 Outlook Improves 41 Silicon Wafers 41 Targets 41 Carve Out 41 Costs Update3 41 Results Reflect 41 Demystifies 41 Uses 41 Bounces 41 Riskier Than 41 Battle Intensifies 41 Remain Steady 41 Unexpectedly Falls 41 Wins Injunction 41 Creeps Up 41 Marches Into 41 Data Suggest 41 Sales Slump 41 Nanosensors 41 Profit Exceeds Estimates 41 Receives Commitment 41 Takes Effect 41 Versus Greenback 41 Pinpoints 41 Raises Hopes 41 Pare Gains 41 Withholds 41 Inventory #,#,# #,#,# 41 Offers Glimpse Into 41 Lawsuit Targets 41 Continues Dominance 41 Feels Pinch 41 Gain Momentum 41 Blood Pressure Drugs 41 Survey Examines 41 Spells Out 41 Subsidizes 41 Bush Threatens Veto 41 Whole Genome Sequencing 41 Rises Less Than 41 Gaining Acceptance 41 Drift Lower 41 Shares Tumble 41 Probe Finds 41 2Q Loss 41 Profits Decline 41 Smaller Than Expected 41 Could Reshape 41 Dwindles 41 Significant Milestone 41 Lowers Costs 41 Expands Footprint 41 Complicates 41 Antibiotic Use 41 Unemployment Climbs 41 Questions Remain About 41 Pulls Down 41 Shows Slight 41 Fights Off 41 Shifts 41 Taps Into